Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street's second-quarter forecasts on Wednesday. The company said that its Spikevax vaccine brought in USD 4.53 billion during the quarter. Analysts were looking for around USD 3.6 billion, according to FactSet. Moderna shares surged at the start of trading on Wednesday. The company's vaccine sales represent a drop from the nearly USD 6 billion in sales the vaccine brought in during the year's first quarter, when a virus surge through the United States pushed more people to seek protection. But those sales could pick up again later this year. Moderna has developed an updated version of its vaccine for a fall booster campaign that combines the original shot with protection against the omicron variant. Federal regulators also recently endorsed the vaccine for children as young as six months old. The COVID-19 vaccine is Moderna's main source of revenue, outside of grants and money from collaborations. Total revenue
80-90% of our global capacity will be in India, says SII CEO Adar Poonawalla
India has added 128,380 cases in the past 7 days
The government on late Tuesday increased the windfall tax on domestically produced crude to Rs 17,750 a tonne from Rs 17,000 a tonne earlier
If approved by the government, this would be the first time a booster dose of a Covid vaccine different from the one used for primary vaccination would be allowed in the country
Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month
The Drug Controller General of India gave its nod to conduct clinical trials for BBIL's intranasal vaccine as booster dose
India has added 129,558 cases in the past 7 days
Due to the constantly emerging new Covid-19 variants, the currently available vaccines may not be as effective
India has added 130,654 cases in the past 7 days
A nationwide vaccination campaign against Covid-19 for children aged between six months to five years was launched in Israel
Analysis shows that by September 29, the country will cover 28.6 per cent of the eligible population of 796 million who will be due for the booster dose
India's COVID-19 case rally rose by 19,673 in a day to reach 4,40,19,811 while active cases reached 143,676
Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected
India saw a marginal decline in Covid cases with 20,409 infections reported in the past 24 hours against previous day's 20,557 count
Over 30 students in Madhya Pradesh's Sagar district were administered Covid-19 jab with a single syringe, a sheer violation of "one needle-one syringe-only one time" protocol.
Four million medical workers will receive a fourth dose of the Covid-19 vaccine amid increasing transmissions triggered by the virus' sub-variants in Indonesia said Health Minister Budi Gunadi Sadikin
Vaccines, sequencing still need govt attention
The count of active cases across India on July 27 saw a decrease of 2,486
The consortium is developing or designing a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants of concern